These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 30912158)
1. A double-virally-inactivated (Intercept-solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells. Barro L; Su YT; Nebie O; Wu YW; Huang YH; Koh MB; Knutson F; Burnouf T Transfusion; 2019 Jun; 59(6):2061-2073. PubMed ID: 30912158 [TBL] [Abstract][Full Text] [Related]
2. Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study. Christensen C; Jonsdottir-Buch SM; Sigurjonsson OE PLoS One; 2020; 15(4):e0220163. PubMed ID: 32294080 [TBL] [Abstract][Full Text] [Related]
3. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells. Chen MS; Wang TJ; Lin HC; Burnouf T N Biotechnol; 2019 Mar; 49():151-160. PubMed ID: 30465908 [TBL] [Abstract][Full Text] [Related]
4. Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells. Barro L; Nebie O; Chen MS; Wu YW; Koh MB; Knutson F; Watanabe N; Takahara M; Burnouf T Cytotherapy; 2020 Aug; 22(8):458-472. PubMed ID: 32536505 [TBL] [Abstract][Full Text] [Related]
5. Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media. Oikonomopoulos A; van Deen WK; Manansala AR; Lacey PN; Tomakili TA; Ziman A; Hommes DW Sci Rep; 2015 Nov; 5():16570. PubMed ID: 26564250 [TBL] [Abstract][Full Text] [Related]
6. Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. Castiglia S; Mareschi K; Labanca L; Lucania G; Leone M; Sanavio F; Castello L; Rustichelli D; Signorino E; Gunetti M; Bergallo M; Bordiga AM; Ferrero I; Fagioli F Cytotherapy; 2014 Jun; 16(6):750-63. PubMed ID: 24529555 [TBL] [Abstract][Full Text] [Related]
7. Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study. Shaz BH; Schäfer R; Fontaine MJ; Norris PJ; McKenna DH; Jin P; Reems JA; Stroncek D; Tanashi M; Marks D; Geng H; Pati S; Cytotherapy; 2024 Jun; 26(6):531-539. PubMed ID: 38043052 [TBL] [Abstract][Full Text] [Related]
8. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. Griffiths S; Baraniak PR; Copland IB; Nerem RM; McDevitt TC Cytotherapy; 2013 Dec; 15(12):1469-83. PubMed ID: 23981539 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Abdelrazik H; Spaggiari GM; Chiossone L; Moretta L Eur J Immunol; 2011 Nov; 41(11):3281-90. PubMed ID: 21874650 [TBL] [Abstract][Full Text] [Related]
10. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells. Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596 [TBL] [Abstract][Full Text] [Related]
11. Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells. Iudicone P; Fioravanti D; Bonanno G; Miceli M; Lavorino C; Totta P; Frati L; Nuti M; Pierelli L J Transl Med; 2014 Jan; 12():28. PubMed ID: 24467837 [TBL] [Abstract][Full Text] [Related]
12. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Gottipamula S; Sharma A; Krishnamurthy S; Majumdar AS; Seetharam RN Biotechnol Lett; 2012 Jul; 34(7):1367-74. PubMed ID: 22476583 [TBL] [Abstract][Full Text] [Related]
13. Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering. Shanbhag S; Mohamed-Ahmed S; Lunde THF; Suliman S; Bolstad AI; Hervig T; Mustafa K Stem Cell Res Ther; 2020 Sep; 11(1):351. PubMed ID: 32962723 [TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical grade human platelet lysates for cultivation of mesenchymal stromal cells from bone marrow and adipose tissue. Juhl M; Tratwal J; Follin B; Søndergaard RH; Kirchhoff M; Ekblond A; Kastrup J; Haack-Sørensen M Scand J Clin Lab Invest; 2016; 76(2):93-104. PubMed ID: 26878874 [TBL] [Abstract][Full Text] [Related]
15. Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells. Viau S; Chabrand L; Eap S; Lorant J; Rouger K; Goudaliez F; Sumian C; Delorme B PLoS One; 2017; 12(8):e0181406. PubMed ID: 28763452 [TBL] [Abstract][Full Text] [Related]
16. Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture. Jonsdottir-Buch SM; Sigurgrimsdottir H; Lieder R; Sigurjonsson OE Cell Transplant; 2015; 24(8):1545-54. PubMed ID: 25198449 [TBL] [Abstract][Full Text] [Related]
17. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Ben Azouna N; Jenhani F; Regaya Z; Berraeis L; Ben Othman T; Ducrocq E; Domenech J Stem Cell Res Ther; 2012 Feb; 3(1):6. PubMed ID: 22333342 [TBL] [Abstract][Full Text] [Related]